Premium
Recommendations for prophylaxis of pregnancy‐related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines: a rebuttal
Author(s) -
Bates S. M.,
Greer I. A.,
Middeldorp S.,
Veenstra D. L.,
Prabulos A.M.,
Vandvik P. O.
Publication year - 2013
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.12347
Subject(s) - rebuttal , medicine , thrombophilia , venous thromboembolism , pregnancy , obstetrics , antiphospholipid syndrome , intensive care medicine , thrombosis , genetics , biology , political science , law
We thank Drs. De Stefano, Grandone, and Martinelli for their comments on our chapter in the 2012 edition of the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines on Antithrombotic Therapy and Prevention of Thrombosis [1]. Modification of our guidelines for antepartum prophylaxis in women with prior venous thromboembolism and in those with asymptomatic thrombophilia was based not on new data, but on a careful reappraisal of the available literature and development of recommendations through rigorous use of the GRADE system [2]. A similar process in 2008 led to significant modifications in our guidance for anticoagulant management of pregnant women with mechanical prosthetic heart valves [3]. This article is protected by copyright. All rights reserve